was no evidence of significant differences in increased oocyte yield per woman randomised (1 study, 44 patients). Without flushing the operative time was significantly shorter, by 3 to 15 minutes (3 studies, P < 0.001) and the dose of pethidine required was significantly less (50 mg versus 100 mg, P < 0.00001).
Authors' conclusions
There is no evidence that follicular aspiration and flushing is associated with improved clinical or ongoing pregnancy rates, nor an increase in oocyte yield. The operative time is significantly longer and more opiate analgesia is required for pain relief during oocyte retrieval. There is a lack of evidence regarding the effect of follicular aspiration and flushing on live birth rates in the identified data.
P L A I N L A N G U A G E S U M M A R Y

Follicular flushing during oocyte retrieval in assisted reproductive technology
Flushing of the follicles during egg collection is not useful, as it prolongs the operating time and increases the need for pain relief without increasing the chances of a pregnancy or increasing the number of eggs recovered. 
S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
B A C K G R O U N D Description of the condition
Assisted reproductive technology (ART) requires the handling of oocytes and embryos outside the woman's body. The technique involves ovarian stimulation, monitoring of follicular growth, oocyte recovery, sperm preparation and insemination, embryo culture, embryo transfer and luteal support.
Description of the intervention
Once maturity of the follicles is achieved, human chorionic gonadotropin (hCG) or recombinant luteinizing hormone (rLH) are used to trigger ovulation. Oocyte pickup is performed approximately 36 hours later, just prior to the actual rupture of the follicles. The technical details of oocyte recovery vary between fertility centres especially with regard to the type of anaesthesia (local, sedation or general), type of aspiration needle (wide or narrow bore, single or double channel), route of retrieval (transvaginal or abdominal), aspiration alone or aspiration with follicular flushing, type of flushing medium and the collecting system. The number of embryos obtained is dependent on the number of oocytes retrieved (Wood 2000) . To maximize the number of oocytes recovered, follicular aspiration followed by one 2-ml flush has been suggested (el Hussein 1992). Waterstone and Parson (1992) reported that the use of double-lumen needles and flushing resulted in 20% more oocytes (Waterstone 1992). On the contrary, other studies found no difference in the number of oocytes collected, fertilization rates, embryo quality or pregnancy rates (Kingsland 1991; Tan 1992; Knight 2001). It was suggested that aspiration without flushing reduced the operative time and decreased the amount of anaesthetic required (Tan 1992).
How the intervention might work
The place of follicular flushing during oocyte recovery in ART is still uncertain. The pros of flushing include the possibility of obtaining more oocytes, and subsequently more embryos. Whether this translates into a higher pregnancy rate and live births remains unknown. The cons of flushing are a longer operative time and larger amounts of required anaesthetics and analgesics. From a patient's perspective, it could also mean higher costs. Moreover, anaesthetics such as propofol could have detrimental effects on embryos, at least in the mouse model (Janssenwillen 1997; Tatone 1998). Flushing could also remove some of the follicular cells that might have an important endocrine luteal support function.
Why it is important to do this review
The prevalence of infertility and the significant costs of assisted conception make it imperative to assess ART techniques to establish which are more effective in terms of attaining a live birth, and cost-beneficial, with a view to improving treatment outcomes. This review provides information for women and clinicians, as well as identifying other aspects that require future study.
O B J E C T I V E S
To determine whether follicular flushing improves the live birth and ongoing pregnancy rates and increases the number of oocytes obtained in women undergoing in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI).
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomised controlled trials (RCTs) were eligible for inclusion if they compared a group undergoing follicular aspiration with the addition of flushing with a control group undergoing follicular aspiration alone, during the process of transvaginal oocyte retrieval for IVF or ICSI. Crossover trials were included only when the pre-crossover data were extractable for analysis. Trials were excluded if the comparison of the flushing method was confounded by a comparison of other methods, such as type of anaesthesia, route of oocyte retrieval, type of aspiration needles, types of flushing media and the embryo transfer technique. For the trial to be included in the meta-analysis, all recruited women had undergone only one cycle of treatment within the context of the trial and had embryos replaced in the uterine cavity in fresh or frozen-thawed cycles. Women were not excluded if embryo replacement did not take place because of a failure of fertilization or the embryo failed to divide further (cleavage arrest).
Types of participants
Participants were women who underwent assisted conception treatment by IVF or ICSI using their own gametes and participated in a trial of follicular flushing during oocyte retrieval.
Types of interventions
Trials were included if they investigated any form of follicular flushing during oocyte retrieval. The effects of follicular flushing were compared to a control group in which flushing was not performed. Trials replacing embryos resulting from oocytes that were derived from mixed groups of flushed and unflushed follicles in the same woman were included. Sensitivity analysis of inclusion or exclusion of these trials was performed, where appropriate. Trials directly comparing different methods of follicular flushing (without a no-flushing control group) were also included but they were analysed and reported separately.
Types of outcome measures Primary outcomes
• Live birth rate, defined as the number of live births per woman randomised
• Ongoing pregnancy or clinical pregnancy rate, defined as the number of clinical pregnancies that were still ongoing at the end of the study; clinical pregnancies were defined as the number of sonologically detected fetal heart pulsations per woman randomised
• Adverse events, including the miscarriage rate per woman randomised and the complication rate for the surgical procedure and during the flushing procedure
Secondary outcomes
• Oocyte yield, defined as the number of oocytes retrieved per woman randomised
• Number of embryo cryopreserved per woman randomised • Duration of oocyte retrieval • Volume of culture medium used to flush the follicles
Search methods for identification of studies Electronic searches
All reports which described (or might have described) randomised controlled trials of follicular flushing were obtained using the following search strategy.
( 
Searching other resources
(1) The citation lists of relevant publications, review articles, abstracts of scientific meetings and included studies were searched. (2) Letters were sent to experts within the field, pharmaceutical companies producing the products being reviewed, and authors of conference abstracts to identify unpublished trials of follicular flushing. (3) Handsearches for RCTs for inclusion in the the MDSG Specialised Register are completed in the relevant journals ,therefore these were searched for any trials on follicular flushing.
Data collection and analysis
Selection of studies
Two review authors (SW, TV) independently scanned titles and abstracts identified from the searches. Potentially relevant trials were selected and independently assessed for inclusion by these review authors using an inclusion and exclusion form. Disagreements were resolved by consensus or through arbitration by a third review author (JB).
Data extraction and management
Data extraction was performed independently by two review authors (SW, TV). Where studies had multiple publications, the main trial was used as the reference and additional details supplemented from the additional sources identified. The review authors corresponded with the authors of the primary studies in order to clarify methodological and data queries.
Assessment of risk of bias in included studies
All assessments of trial quality and data extraction were performed independently by two review authors (SW, TV) using forms that were designed for the review. The trials were evaluated using the Cochrane risk of bias assessment tool (refer to Characteristics of included studies) to assess the following. Sequence generation (e.g. low risk: investigators used random number tables, computer-generated random numbers, shuffling cards; high risk: sequence generated from date of birth, hospital or clinic record number). Allocation concealment (e.g. low risk: central allocation, sequentially numbered sealed opaque envelopes; high risk: open number allocation schedule, alternation or rotation). Blinding (e.g. low risk: blinding of participants or key study personnel or both, use of placebo; low risk: incomplete or no blinding, comparison group with no treatment). Attrition bias (e.g. low risk: no missing outcome data; high risk: attrition equal to or greater than 20%). Selective outcome reporting and other potential sources of bias (e.g.low risk: study protocol available; high risk: not all primary outcomes were reported, outcomes reported were not pre-specified). Additional information was recorded for trial design and setting, trial participants, interventions and outcomes. Any discrepancies in quality assessment or data extraction were resolved by consensus during discussions with the third review author (JB). Additional information on trial methodology and actual original trial data were sought from the authors of trials that appeared to meet the eligibility criteria but had aspects of methodology that were unclear, or where the data were in a form unsuitable for metaanalysis.
Measures of treatment effect
Statistical analysis was performed in accordance with the guidelines for statistical analysis developed by The Cochrane Collaboration (Higgins 2009. For dichotomous data (for example live births), results for each trial were expressed as odds ratios (OR) with 95% confidence intervals (CI) and these were then combined for metaanalysis on RevMan 5.0 software using a random-effects model. For continuous data, mean differences between treatment groups were calculated.
Unit of analysis issues
The primary analysis was conducted as per woman randomised. Data reported in a form that did not enable valid analysis (that is per cycle rather than per woman, where women undertook more than one cycle) were summarised in the review but did not contribute to a meta-analysis.
Dealing with missing data
The data were analysed on an intention-to-treat basis, as far as possible, and attempts were made to obtain missing data from primary authors.
Assessment of heterogeneity
Heterogeneity between the results of different trials was examined using the I 2 statistic (Higgins 2009). An I 2 statistic greater than 50% is indicative of substantial heterogeneity. Where heterogeneity was detected, subgroup or sensitivity analysis was conducted to attempt to explain this.
Assessment of reporting biases
In view of the difficulty in detecting and correcting for publication bias and other reporting biases, the authors aimed to minimise the potential for bias by searching multiple databases and grey literature. Where 10 or more trials were identified, a funnel plot was produced.
Data synthesis
The data from the primary studies was combined using a randomeffects model in the comparison: follicular aspiration + flushing versus aspiration only. Data were not stratified. An increase in the odds of a particular outcome which may be beneficial (for example live birth) or detrimental (for example adverse effects) were displayed graphically in the meta-analyses to the right of the centre line and a decrease in the odds of an outcome was to the left of the centre line.
Subgroup analysis and investigation of heterogeneity
Where heterogeneity was identified, differences in trial design were investigated through the following subgroups. Where possible, data on these subgroups were extracted directly from the included trials. Where not reported, the mean trial data (for example, the mean trial FSH level) was used to place the whole trial in one of the subgroups.
Sensitivity analysis
Where required, sensitivity analyses were undertaken to examine the stability of results in relation to: (a) adequacy of allocation concealment, by removing those trials with unclear or inadequate allocation concealment; (b) adequacy of the randomisation process, by removing those trials with no stated method of randomisation or where the method was unclear. Although all potential trials might be statistically homogeneous, differences in clinical parameters can be considerable (clinical heterogeneity). These differences were taken into account when analysing and interpreting the pooled results. Clinical heterogeneity in subfertility cannot be avoided because most centres use their own materials and methods, which can vary in a number of parameters. When trials meet the inclusion criteria and they have performed the same intervention, we considered it appropriate to pool their results.
Updating
It is the intention of the review authors that a new search for RCTs will be performed every two years and the review updated accordingly.
R E S U L T S Description of studies
See: Characteristics of included studies; Characteristics of excluded studies; Characteristics of studies awaiting classification.
Results of the search
Sixteen trials providing data on follicular flushing during oocyte retrieval in assisted reproductive cycles were identified (Lenz 1987 
Risk of bias in included studies
Allocation
Allocation concealment was done using sequentially numbered and sealed envelopes in two studies (Tan 1992; Levens 2009) but was not stated in the other two studies.
Blinding
Blinding of participants and researchers was reported by Levens 2009. None of the remaining included studies reported on blinding.
Incomplete outcome data
All the women randomised were analysed.
Selective reporting
All of the studies reported on the a priori outcomes.
Other potential sources of bias
No other sources of bias were identified in this review.
Effects of interventions
See: Summary of findings for the main comparison Summary Table
Live birth
No studies reported on the outcome of live birth.
Ongoing and clinical pregnancy per woman randomised
Ongoing and clinical pregnancies per woman randomised were reported in three studies (Kingsland 1991; Tan 1992; Levens 2009) in a total of 164 women. There was no evidence to suggest that follicular aspiration plus flushing of the follicles increased the chance of ongoing and clinical pregnancy when compared with aspiration alone (OR 1.17, 95% CI 0.57 to 2.38) (Figure 3) . 
Adverse events
None of the studies reported on the outcome of miscarriage. One study (Tan 1992) reported on three adverse events: blockage of the needle (OR 7.44, 95% CI 0.37 to 147.92), vomiting (OR 5.21, 95% CI 0.24 to 111.24) and hypotension (OR 5.21, 95% CI 0.24 to 111.24). There was no evidence of a difference between follicular aspiration plus flushing compared with follicular aspiration alone for any of these outcomes (Figure 4 ). In the study by Tan 1992 it was reported that there was significantly less analgesia required with the aspiration alone procedure compared with the addition of flushing (median 50 mg, range 50 to 100 mg for follicular aspiration alone; median 100 mg, range 50 to 100 mg for follicular aspiration plus flushing). 
Oocyte yield
Data regarding oocyte retrieval were presented in three studies (Kingsland 1991; Tan 1992; Levens 2009). However, the data were presented as per cycle and not per woman randomised and therefore could not be used in the meta-analysis due to unit of analysis issues. Scott 1989 reported a non-significant difference between single and double-lumen needle used for aspiration and flushing (OR 0.4, 95% CI -0.43 to 1.43). Tan 1992 made the interesting remark that a surgeon who knew he was going to flush the follicle could be less cautious in emptying the follicle as completely compared with when it was going to aspirated only. They proposed that surgeon who started flushing the moment the follicle appeared empty could find a high proportion of oocytes in the flushing fluid.
Number of embryo cryopreserved
There were no data relating to this outcome. 
Duration of procedure
Volume of culture medium
Kingsland 1991 reported that a total of 10 ml flushing medium was used in the procedure (maximum of 2 ml at each flush) and (Scott 1989) reported 2 to 3 ml of fluid used for flushing, with one or more washes. This has implications for cost effectiveness.
D I S C U S S I O N
Summary of main results
There were no studies which reported on the outcome of live birth. There was no evidence to support the use of the addition of flushing to follicular aspiration in oocyte retrieval. Aspiration plus flushing resulted in additional theatre time and analgesia requirements. Adverse effects were poorly reported overall. Refer to the Summary of findings for the main comparison for further details.
Overall completeness and applicability of evidence
The number of eligible studies that evaluated the potential beneficial effect of follicular aspiration and flushing was limited. The studies failed to follow women up to obtain data on live births. Flushing medium is relatively expensive and may not be an option for all facilities, or women, internationally. There are potential differences in technique and operator experience which may affect results, such as the techniques of oocyte aspiration, which were not controlled or described in the trials in this review. For example, in a recent retrospective study (Dahl 2009) it was shown that retrievals that utilised follicle curetting (gently and rapidly rotating the needle in a clockwise and counter-clockwise fashion inside the follicle after complete aspiration of the follicular fluid) could significantly increase the number of oocytes retrieved over aspiration without curetting (13.9 + 0.6 versus 11.4 + 0.6 oocytes; P = 0.003).
Another possibility is that the vacuum is usually deactivated after the needle exits the follicle in the aspiration-only group. In this manner, follicular fluid from the next follicle will flush any oocyte remaining in the dead space into the collection tube. However, the vacuum has to be deactivated just before flushing and while the needle is still inside the follicle in the aspiration with flushing group. Theoretically the negative pressure inside the follicle can suck the oocyte back (Horne 1996) . This oocyte will, therefore, be either recovered in the flushing fluid or lost.
Quality of the evidence
Four randomised trials were available for analysis, comprising a total of 208 women. Moreover, the size of these trials was small (< 60 women per group), their methodological quality appears to be variable, and only a limited number of trials provided data for individual outcomes. With these limitations one should be very cautious in concluding that there is no benefit in the flushing of the follicles after aspiration.
Potential biases in the review process
There are some flaws in the presentation of the data in terms of unit of analysis issues, where data are presented per cycle rather than per woman randomised. Only one study reported on the adverse effects associated with the procedure. The authors of the present review have attempted to minimise bias by conducting a rigorous search of the literature, using published and unpublished sources.
Agreements and disagreements with other studies or reviews
Studies that performed routine flushing after aspiration of the follicles reported that additional oocytes could always be obtained. For example, el Hussein 1992 obtained 40.3% of collected oocytes from the initial aspiration, 41.3% from the dead space in the collecting system, 13.7% in the first 2-ml flush, and 4.7% from the second 2-ml flush. Waterstone 1992 concluded that 20% more oocytes were obtained than with aspiration alone in 50 patients who had follicle aspiration with flushing. Bagtharia 2005 found 40% of the oocytes in the primary aspiration without flushing of the follicle, while up to 82% of oocytes were retrieved with two flushes and 97% retrieved in up to four flushes. Mendez Lozano 2008 observed 46.8% oocyte recovery rate with aspiration only, compared with 84.6% with additional follicular flushing in 165 infertile women with low ovarian reserve, undergoing 271 consecutive minimal stimulation IVF cycles. The findings from this review found no support for an increase in oocyte retrieval although this is based on a single trial providing data per woman randomised. The data obtained in the studies above may be misinterpreted if they are reported per cycle rather than per woman randomised.
A U T H O R S ' C O N C L U S I O N S
Implications for practice
The available data do not support routine flushing of the follicles after aspiration. This approach does not increase the chance of clinical pregnancy or the number of oocytes obtained. There is evidence that aspiration with flushing prolongs the retrieval time and may increase the requirement for analgesics during oocyte retrieval.
Implications for research
Up to now, there has been no study that compares the effect of follicle aspiration against aspiration and flushing in terms of live births or miscarriages per woman randomised. Further studies should include details on the technique of aspiration and flushing, such as follicle curetting, the completeness of follicle emptying before flushing. The advantage of follicle aspiration and flushing in the retrieval of immature oocytes for in vitro maturation (IVM) with ICSI and natural cycle IVF deserves further study.
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C H A R A C T E R I S T I C S O F S T U D I E S Characteristics of included studies [ordered by study ID]
Kingsland 1991
Methods Prospective randomised trial Interventions Pre-treatment with OCPs during the cycle preceding ovarian stimulation. A combination of rFSH (Gonal-F) and hMG (Repronex, Ferring) were given twice daily. Adequate follicular development assessed by serial serum E2 ultrasound. hCG 10,000 IU given, followed by transvaginal oocyte retrieval 34-36 hrs later. Assignment to single or double lumen group was done immediately before oocyte retrieval. Computerised randomisation in blocks of 10-20 was used to ensure balanced group size. Concealment achieved by using sequentially numbered, opaque envelopes that were opened in the OR after anaesthesia was administered. The length and diameter of retrieval needles were stan- 
Interventions
All patients underwent gonadotropin stimulation, using previously described protocols (in textbook, no details given in the paper) Retrieval with single lumen needle (SLN) (n=22) was done using Swe-Med needle (outer diameter 1.5 mm, inner diameter 1 mm). The follicle was aspirated with a hand-held 20-ml syringe, remove the needle from the patient, and then aspirate an additional 2 ml of heparinised Dulbecco's solution through the system to wash the fluid in the dead space back into the syringe The double-lumen needle (DLN; Swe-Med Lab, Frolunda, Sweden) had an inner diameter of the aspiration lumen of 1 mm and the outer diameter was 1.6 mm. The follicle was aspirated and then 1-3 ml of heparinised Dulbecco's solution was injected in to the follicle through the second port. This volume was then aspirated back into the syringe. The lavage was performed one more time until the oocyte was recovered or until the follicle was not reexpanding well, before proceeding to the next follicle Pain relief: method not mentioned.
Outcomes
Number of follicles aspirated and number of oocytes retrieved Incidence of fractured zona in both groups 
Notes
Risk of bias
Tan 1992
Methods Prospective randomised study Participants Country: UK Site: 100 women undergoing IVF treatment at an assisted conception unit Median age for Group 1 was 32 (25 to 42 years), and for Group 2 was 32.5 years (23 to 43 years) Exclusion: women who had developed >25 or <4 follicles wider than 14 mm diameter on the day of hCG administration Interventions Long follicular protocol, starting buserelin acetate (Suprefact; Hoechst, Hounslow, UK) administered intranasally (200 µg 4 hourly) on day 1 or 2 of the menstrual cycle. When serum estradiol concentration was < 200 pmol/L, human menopausal gonadotropin (Pergonal; Serono, Welwyn Garden City, UK) was started at 2-6 ampoules daily. HCG (Profasi; Serano) 10,000 IU was administered when there were at least 4 follicles > 14mm diameter and the mean diameter of the largest follicle was >20mm Transvaginal US guided follicle aspiration was performed 33-38 hours post hCG as an outpatient procedure. Pain relief achieved using IV pethidine 50-100 mg in bolus doses of 25 mg as required Aspiration using JP6L double-channel needle (Casmed, Cheam, UK). A maximum aspiration pressure of 100 mm Hg was used in both groups Group 1 (Aspiration only; n=50): inner channel of needle removed to convert it into a single channel needle. Each follicle aspirated until empty. The probe was moved around until all follicular fluid was aspirated as evidenced by some blood stained fluid in the tubing. The same procedure was repeated until all follicles >10 mm had been aspirated from the first ovary. After clearing the dead space in the needle the procedure was repeated in the second ovary Group 2 (Aspiration and flushing, n=50): double channel needle was used and the follicle aspirated through the inner channel. This initial aspirate was termed A1. Once the follicle had been emptied the collecting tube was changed and, with the valve open, flushing medium was injected until 1.5 ml of fluid had been collected. This was termed A2. A1 and A2 were examined separately and if no oocyte was observed the follicle was flushed All patients had repeated flushing of the follicles. The study compared the number of oocytes obtained with each flushing after primary aspiration of the follicle. They concluded that 40% of the oocytes were retrieved with the primary aspiration without flushing of the follicle, while up to 82% of oocytes were retrieved with two flushes and 97% retrieved in up to 4 flushes The study was excluded as it was not an RCT and no control (aspiration only) group was present The study evaluated 100 consecutive patients undergoing 100 cycles of IVF. Four patients were excluded because their embryos were electively cryopreserved. The study reported an overall oocyte recovery rate of 87.8%. Of the 1046 oocytes collected, 40.3% were from the initial aspiration (A1), 41.3% were from the dead space in the collecting system (A2), 13.7% were in the first 2-ml flush (F1), and 4.7% were from the second 2-ml flush (F2).There were comparable numbers of viable and fertilized oocytes and cleaved, transferred and frozen embryos in tubes A1 and A2, but all these parameters were significantly lower in tubes F1 and F2 (P<0.0001). All these parameters were also significantly higher in F1 compared with F2 (P<0.001) , except for the numbers of embryos frozen, in which there was no difference. The overall pregnancy rate/ cycle was 28.1% and the pregnancy rate per ET was 31%. There was no pregnancy in any of the cycles in which embryos originating from F2 were transferred, nor was there pregnancy in cycles in which only embryos from F1 were transferred. They concluded that follicular aspiration together with one 2-ml flush maximises the recovery of oocytes that will result in pregnancies Reason for exclusion: not a randomised study. Aspiration done in all cases 
S O U R C E S O F S U P P O R T
Internal sources
• none, Not specified.
External sources
D I F F E R E N C E S B E T W E E N P R O T O C O L A N D R E V I E W
In the protocol, we planned to compare single versus multiple flushes, and different volumes for flushing, in terms of live births and ongoing pregnancies in women undergoing IVF and ICSI. However, as aspiration and aspiration with flushing do not yield any difference in clinical and ongoing pregnancies, or in the number of oocytes obtained, this analysis becomes both irrelevant and unnecessary and the secondary objective was removed from the final review.
Clinical pregnancy has been moved to a primary outcome, with ongoing pregnancy.
A number of secondary outcomes have been removed from the protocol as they do not contribute to the overall aim of the study, or they represent methodological issues of bias where data are not attributable to per woman randomised. These outcomes are: fertilisation rate, rates of embryo cleavage, rates of congential and chromosomal abnormalities, amount of anaesthetic required, cost per oocyte retrieval procedure.
The outcome of adverse events has been added as a primary outcome 
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